KARINA GEBHART: Open Payments
NPI 1275713166 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 64 payments from 17 companies in 2025. Trend: 2023 $1,204 · 2024 $1,884 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $276 |
| Amgen Inc. | 13 | $265 |
| ABBVIE INC. | 9 | $214 |
| PFIZER INC. | 9 | $200 |
| Novo Nordisk Inc | 6 | $136 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Astellas Pharma US Inc | 2 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $61 |
| Exact Sciences Corporation | 2 | $54 |
| Hologic Sales and Service, LLC | 2 | $50 |
Products named: OTEZLA, NEXIUM, NURTEC ODT, UBRELVY, BREZTRI, Wegovy, QULIPTA, SHINGRIX.
Industry payments across CO — which companies pay providers there.
